<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336222">
  <stage>Registered</stage>
  <submitdate>12/11/2010</submitdate>
  <approvaldate>16/11/2010</approvaldate>
  <actrnumber>ACTRN12610000990022</actrnumber>
  <trial_identification>
    <studytitle>Translabial Tridimensional Ultrasound Imaging of Uterine Cervical Dilatation in First Stage of Labor</studytitle>
    <scientifictitle>Intrapartum Translabial Tridimensional Ultrasound Imaging of Uterine Cervical Dilatation in First Stage of Labor - A double Blind Study</scientifictitle>
    <utrn>U1111-1117-8667</utrn>
    <trialacronym />
    <secondaryid>No secundary ID</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Spontaneous labor in healthy, low risk, term, singelton parturients</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Normal pregnancy</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intrapartum translabial 3D ultrasonographic imaging of uterine cervix using a Voluson 750 ultrasound system, GE Healthcare, Kretztechnik, Zipf, Austria, with a RAB2-5-RS 2- to 5-MHz convex 4-dimensional probe.
A wrapped ultrasound transducer is placed over patient's perineum, A volume acquisition (lasting around 30seconds) is repeated hourly until cervical dilatation of 5cm is reached</interventions>
    <comparator>Ultrasound imaging results were compared to digital vaginal examainations done by delivery room personel according delivery room standards of care</comparator>
    <control>Active</control>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The study end point was the detection of transition from latent to active phase in first stage of labor defined as a documented change in cervical dilatation from 3cm to 5cm</outcome>
      <timepoint>the duration of entire labor</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>time to reach 3 and 5 cm cervical dilatation</outcome>
      <timepoint>the duration of entire labor</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Included were all term (equal or greater than 37 weeks) low risk singleton parturients admitted to our delivery room  with the diagnosis of labor as defined elsewhere who agreed to participate in the study  and signed a detailed informed consent</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Excluded were preterm patients, multiple pregnancies and non vertex presentations. Participation was stopped in case of patient or delivery room team request; and in case of an obstetrical risk factor such as nonreassuring fetal heart rate tracing, vaginal bleeding, pre-eclampsia or the need for emergency intervention.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/02/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Tzeriffin</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Ariel L ZImerman</primarysponsorname>
    <primarysponsoraddress>Obstetrics and Gynecological Division
Asaf Harofe Medical Center
Tzerifin 70300
Israel
Tel- 972-8-9779000
Fax-972-3-5343848</primarysponsoraddress>
    <primarysponsorcountry>Israel</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Ariel L ZImerman</fundingname>
      <fundingaddress>Obstetrics and Gynecological Division
Asaf Harofe Medical Center
Tzerifin 70300
Israel
Tel- 972-8-9779000
Fax-972-3-5343848</fundingaddress>
      <fundingcountry>Israel</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Obstetrics and Gynecological Division Asaf Harofe Medical Center</sponsorname>
      <sponsoraddress>Obstetrics and Gynecological Division
Asaf Harofe Medical Center
Tzerifin 70300
Israel
Tel- 972-8-9779000
Fax-972-3-5343848</sponsoraddress>
      <sponsorcountry>Israel</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Proff. Rony Maymon</othercollaboratorname>
      <othercollaboratoraddress>Obstetrics and Gynecological Division
Asaf Harofe Medical Center
Tzerifin 70300
Israel
Tel- 972-8-9779000
Fax-972-3-5343848</othercollaboratoraddress>
      <othercollaboratorcountry>Israel</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Sudy objective- To assess the use of non invasive intrapartum translabial 3D-US in the diagnosis of latent to active phase transition defined as an increase in cervical dilatation from 3cm to 5cm, and to compare it to digital vaginal examination.
Study methods- An observational prospective double blind clinical study. Hourly consecutive translabial 3D-US volumes are obtained in singleton term patients admitted to delivery room. Sonographers are blind to patients digital vaginal examination partogram. Patients and delivery room personnel are blind to sonographic results. Obtained volumes will be processed offline. Ultrasound maximal cervical diameter and vaginal digital examination will be compared.</summary>
    <trialwebsite>none</trialwebsite>
    <publication>none</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Asaf Harofe Helsinky Committee</ethicname>
      <ethicaddress>Asaf Harofe Medical Center
Tzerifin 70300
Israel
Tel- 972-8-9779000
Fax-972-3-5343848</ethicaddress>
      <ethicapprovaldate>21/05/2009</ethicapprovaldate>
      <hrec>24/09*1</hrec>
      <ethicsubmitdate />
      <ethiccountry>Israel</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Ariel Zimerman</name>
      <address>Obstetric and Gynecological Division
Asaf Harofe Medical Center
Tzeriffin 70300
Israel
Tel- 972-8-9779000
Fax- 972-3-5343848</address>
      <phone>972-52-5616002</phone>
      <fax>972-3-5343848</fax>
      <email>zimermanariel@hotmail.com</email>
      <country>Israel</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ariel Zimerman</name>
      <address>Obstetric and Gynecological Division
Asaf Harofe Medical Center
Tzeriffin 70300
Israel
Tel- 972-8-9779000
Fax- 972-3-5343848</address>
      <phone>972-52-5616002</phone>
      <fax>972-3-5343848</fax>
      <email>zimermanariel@hotmail.com</email>
      <country>Israel</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ariel ZImerman</name>
      <address>Obstetric and Gynecological Division
Asaf Harofe Medical Center
Tzeriffin 70300
Israel
Tel- 972-8-9779000
Fax- 972-3-5343848</address>
      <phone>972-52-5616002</phone>
      <fax>972-3-5343848</fax>
      <email>zimermanariel@hotmail.com</email>
      <country>Israel</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>